Saturday 17 October 2026 Export RNTX’s income statement to Excel — free account

Rein Therapeutics Inc.

In the quarter to June 2026, EPS grew 64.3% and free cash flow fell 34.6%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

0.59 0.04 −6.35%

Follow RNTX

Alert me

Market cap: $54.2M
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	(229.07%)	533.38%	351.84%	(753.55%)
ROA Full definition →		(74.57%)	(115.51%)	(119.66%)	(80.62%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		10,330.70%	2,689.91%	613.49%	(156.76%)
Free Cash Flow per Share Full definition →		(0.79)	(0.76)	(0.55)	(0.28)
Free Cash Flow Full definition →		(20.95)	(19.36)	(16.61)	(18.83)
Other line items
Cash ROIC Full definition →		(400.40%)	77.84%	57.34%	(37.04%)
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Operating CF/Net income Full definition →		0.36	0.39	0.33	0.38
Depreciation/Fixed assets Full definition →		0.00	0.00	0.00	0.00
Capex/Depreciation Full definition →		0.00	0.00	0.00	0.00
Revenue per Share Full definition →		0.00	0.00	0.00	0.00
Operating CF per Share Full definition →		(0.79)	(0.76)	(0.55)	(0.28)
Capex per Share Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly